They were observed mostly within the first two years (79.4 %, 95%CI, 71.2 %–87.6 %) and showed a decreasing trend over time.
← all excerpts
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer.
1
—
—